Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Whitney Haring-Smith resigned as Chairman at Envoy Medical, Inc..
- Action
- resigned
- Role
- Chairman
Exact text from the filing
Charles Brynelsen replaced Whitney Haring-Smith as chairman
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Glen A. Taylor was elected as Director at Envoy Medical, Inc..
- Action
- elected
- Role
- Director
Exact text from the filing
each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Diane Dewbrey resigned as Director at Envoy Medical, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of Diane Dewbrey, Daniel Hirsch and Priya Cherian Huskins resigned as directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Daniel Hirsch resigned as Director at Envoy Medical, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of Diane Dewbrey, Daniel Hirsch and Priya Cherian Huskins resigned as directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Brent Lucas was elected as Director at Envoy Medical, Inc..
- Action
- elected
- Role
- Director
Exact text from the filing
each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Mona Patel was elected as Director at Envoy Medical, Inc..
- Action
- elected
- Role
- Director
Exact text from the filing
each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.9
Daniel Hirsch resigned as other_named_officer at Envoy Medical, Inc..
- Action
- resigned
Exact text from the filing
each of Whitney Haring-Smith and Daniel Hirsch resigned as executive officers
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Whitney Haring-Smith was elected as Director at Envoy Medical, Inc..
- Action
- elected
- Role
- Director
Exact text from the filing
each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Brent Lucas was appointed as Chief Executive Officer at Envoy Medical, Inc..
- Action
- appointed
- Role
- Chief Executive Officer
Exact text from the filing
Brent Lucas was appointed to serve as the Chief Executive Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Charles Brynelsen was elected as Director at Envoy Medical, Inc..
- Action
- elected
- Role
- Director
Exact text from the filing
each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Susan J. Kantor was elected as Director at Envoy Medical, Inc..
- Action
- elected
- Role
- Director
Exact text from the filing
each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Janis Smith-Gomez was elected as Director at Envoy Medical, Inc..
- Action
- elected
- Role
- Director
Exact text from the filing
each of Brent Lucas, Charles Brynelsen, Whitney Haring-Smith, Susan J. Kantor, Mona Patel, Janis Smith-Gomez and Glen A. Taylor were elected as directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
David R. Wells was appointed as Chief Financial Officer at Envoy Medical, Inc..
- Action
- appointed
- Role
- Chief Financial Officer
Exact text from the filing
David R. Wells was appointed to serve as the Chief Financial Officer
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Charles Brynelsen was appointed as Chairman at Envoy Medical, Inc..
- Action
- appointed
- Role
- Chairman
Exact text from the filing
Charles Brynelsen appointed as chairman of the board of directors
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.9
Whitney Haring-Smith resigned as other_named_officer at Envoy Medical, Inc..
- Action
- resigned
Exact text from the filing
each of Whitney Haring-Smith and Daniel Hirsch resigned as executive officers
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Priya Cherian Huskins resigned as Director at Envoy Medical, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
each of Diane Dewbrey, Daniel Hirsch and Priya Cherian Huskins resigned as directors
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.97
Envoy Medical, Inc.: Adopted amended and restated bylaws effective September 29, 2023 (effective 2023-09-29).
- Change
- bylaw amendment
- Effective
- 2023-09-29
Exact text from the filing
On the Closing Date, in connection with the consummation of the Business Combination, the Company adopted the Second Amended and Restated Certificate of Incorporation (as amended and restated, the “ Charter ”) and amended and restated bylaws (as amended and restated, the “ Bylaws ”).
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.99
Envoy Medical, Inc.: Company ceased being a shell company as a result of the Business Combination (effective 2023-09-29).
- Change
- shell status
- Effective
- 2023-09-29
Exact text from the filing
As a result of the Business Combination, the Company ceased being a shell company.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.98
Envoy Medical, Inc.: Adopted Second Amended and Restated Certificate of Incorporation effective September 29, 2023, including amendments proposed by Charter Proposals (effective 2023-09-29).
- Change
- charter amendment
- Effective
- 2023-09-29
Exact text from the filing
On the Closing Date, in connection with the consummation of the Business Combination, the Company adopted the Second Amended and Restated Certificate of Incorporation (as amended and restated, the “ Charter ”) and amended and restated bylaws (as amended and restated, the “ Bylaws ”).
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Envoy Medical, Inc. underwent a change of control involving Envoy Medical Corporation for Each share of Envoy Common Stock converted into the right to receive a number of shares of New Envoy Common Stock equal to the Exchange Ratio of 0.063603; Spons (closed 2023-09-29).
- Action
- change of control
- Counterparty
- Envoy Medical Corporation
- Consideration
- Each share of Envoy Common Stock converted into the right to receive a number of shares of New Envoy Common Stock equal to the Exchange Ratio of 0.063603; Spons
- Closing
- 2023-09-29
Exact text from the filing
share of Envoy Common Stock was converted into the right to receive pursuant to the applicable provisions of the Business Combination Agreement. The Exchange Ratio was equal to 0.063603. In addition, pursuant to the subscription agreement, dated April 17, 2023 (as amended to date, the “ Subscription Agreement ”), by and between Anzu and Anzu SPAC GP I LLC (the “
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.